Related Experiment Videos

The role of COX-2 in heart pathology

J M Streicher1, Y Wang

  • 1Department of Anesthesiology, Physiology and Medicine, Molecular Biology Institute, David Geffen School of Medicine, UCLA, Los Angeles, CA 90095, USA.

Cardiovascular & Hematological Agents in Medicinal Chemistry
|January 29, 2008
PubMed

Insights

Cyclooxygenase-2 (COX-2) plays a controversial role in heart health. This review clarifies COX-2

Area of Science:

  • Cardiovascular Physiology
  • Inflammation Biology
  • Pharmacology

Background:

  • Cyclooxygenase-2 (COX-2) is a critical enzyme in prostaglandin synthesis and a target for anti-inflammatory drugs.
  • The role of COX-2 in cardiac function and pathology is debated, with conflicting evidence suggesting both detrimental and protective effects.
  • COX-2 inhibitors have been linked to increased heart disease risk in chronic users, highlighting the need for clarity.

Purpose of the Study:

  • To provide a comprehensive background on COX-2's general roles in pathophysiology and expression control.
  • To elucidate the functional role of COX-2 in human heart pathologies using clinical and experimental data.
  • To explore molecular signaling cascades regulating COX-2 in cardiomyocytes for a mechanistic understanding.

Main Methods:

  • Review of existing literature on COX-2 in general pathophysiology and cardiac function.
  • Analysis of human studies involving COX-2 pharmacological inhibitors and COX-2 expression in heart disease.
  • Exploration of experimental evidence on intracellular signaling pathways regulating COX-2 in cardiomyocytes.
  • Examination of genetic manipulation of COX-2 in mouse models.

Main Results:

  • Conflicting experimental data exists regarding the detrimental versus protective roles of COX-2 in cardiac models.
  • COX-2 pharmacological inhibitors have shown varied effects in human heart pathologies.
  • Specific intracellular signaling cascades regulating COX-2 expression in cardiomyocytes have been identified.

Conclusions:

  • A deeper mechanistic understanding of COX-2's role in cardiac physiology and pathology is needed.
  • Further research, including genetic manipulation studies, is essential to resolve the controversy surrounding COX-2 in heart disease.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...